Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08NDE
|
||||
Former ID |
DIB007143
|
||||
Drug Name |
BLZ-945
|
||||
Synonyms |
BLZ-945; CSF-1R inhibitor (bone cancer); CSF-1R inhibitor (bone cancer), Novartis
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Bone cancer [ICD10:C41.0] | Investigative | [543010] | ||
Company |
Novartis Institutes for BioMedical Research Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H22N4O3S
|
||||
InChI |
InChI=1S/C20H22N4O3S/c1-21-19(26)16-10-13(8-9-22-16)27-12-6-7-15-18(11-12)28-20(24-15)23-14-4-2-3-5-17(14)25/h6-11,14,17,25H,2-5H2,1H3,(H,21,26)(H,23,24)/t14-,17-/m1/s1
|
||||
InChIKey |
ADZBMFGQQWPHMJ-RHSMWYFYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Macrophage colony-stimulating factor receptor | Target Info | Inhibitor | [543466] | |
NetPath Pathway | Leptin Signaling Pathway | ||||
RANKL Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.